Vasculitis Mimics for MRCP Part 1
- Crack Medicine

- 14 hours ago
- 3 min read
TL;DR
Integration: Vasculitis Mimics is a high-yield MRCP Part 1 topic because many non-vasculitic conditions present with similar systemic and organ-specific features. Distinguishing mimics—especially infection, malignancy, and drug-induced syndromes—from true vasculitis relies on recognising patterns and using targeted investigations. The key exam principle is simple: exclude infection before starting immunosuppression.
Why this matters
In MRCP Part 1, vasculitis is rarely tested in isolation. Instead, questions challenge your ability to differentiate true vasculitis from its mimics, often using subtle clinical clues. This is not just exam technique—it reflects real-world clinical safety, where misdiagnosis can lead to inappropriate immunosuppression and harm.
A structured revision approach can be found in the MRCP Part 1 overview, and applying knowledge through questions is essential via Free MRCP MCQs.
Core sections
1. What are vasculitis mimics?
Vasculitis mimics are conditions that produce multisystem inflammation, rash, organ dysfunction, or ischaemia without primary inflammation of blood vessels. These conditions can closely resemble small-, medium-, or large-vessel vasculitis in both clinical and laboratory features.
2. The 5 most tested mimic categories
A. Infection (most important)
Infections are the most common and most dangerous mimics.
Infective endocarditis → embolic phenomena, glomerulonephritis, purpura
Hepatitis B/C → polyarteritis nodosa-like or cryoglobulinaemia
Tuberculosis → constitutional symptoms, granulomatous inflammation
Exam clue: Fever + positive cultures + immune complex features (low complement)
B. Malignancy
Haematological malignancies frequently mimic vasculitis:
Lymphoma → fever, weight loss, vasculitic rash
Multiple myeloma → renal dysfunction, neuropathy
Exam clue: Monoclonal protein spike or unexplained cytopenias
C. Thromboembolic disease
These present with ischaemic features rather than inflammation:
Cholesterol embolisation → livedo reticularis, acute kidney injury
Atrial myxoma → systemic emboli
Exam clue: Sudden onset after vascular procedure or anticoagulation
D. Drug-induced syndromes
Commonly tested drugs include:
Hydralazine
Propylthiouracil
Cocaine (levamisole contamination)
Exam clue: ANCA positivity with a clear temporal drug relationship
E. Connective tissue diseases
These overlap significantly with vasculitis:
Systemic lupus erythematosus (SLE)
Antiphospholipid syndrome (APS)
Exam clue: Positive ANA/dsDNA or antiphospholipid antibodies; APS causes thrombosis, not inflammation
3. High-yield comparison table
Feature | True Vasculitis | Infection Mimic | Thromboembolism |
Fever | Common | Common | Rare |
CRP/ESR | Raised | Raised | Mild ↑ |
Blood cultures | Negative | Positive | Negative |
ANCA | Often positive | Usually negative | Negative |
Complement | Normal/low | Low | Normal |
Biopsy | Vessel inflammation | Immune complex/infection | Cholesterol clefts |
Treatment | Immunosuppression | Antibiotics | Anticoagulation |
4. 10 high-yield exam points
Always exclude infection before starting steroids
ANCA is supportive, not diagnostic
Cryoglobulinaemia strongly suggests Hepatitis C infection
Low complement → immune complex disease, not ANCA vasculitis
Endocarditis commonly mimics small vessel vasculitis
Drug-induced ANCA vasculitis often has multi-antigen positivity
Cholesterol emboli follow angiography or vascular surgery
Renal involvement requires biopsy before immunosuppression
Eosinophilia suggests EGPA or drug reaction
APS causes thrombosis, not true vasculitis
Practical examples / mini-cases
Mini-case (MRCP style)
A 58-year-old man presents with fever, weight loss, haematuria, and a purpuric rash. Blood tests show raised CRP and positive c-ANCA. Urinalysis reveals red cell casts. Blood cultures are pending.
What is the next best step?
A. Start high-dose steroidsB. Start cyclophosphamideC. Perform renal biopsyD. Start anticoagulation
Correct answer: C. Perform renal biopsy
Explanation: Although ANCA-associated vasculitis is likely, infection (especially endocarditis) must be excluded first. A renal biopsy confirms diagnosis before initiating immunosuppression. Starting steroids prematurely is a classic MRCP trap.

Common pitfalls (5 bullets)
Assuming ANCA positivity confirms vasculitis
Missing infective endocarditis as a mimic
Starting immunosuppression before excluding infection
Ignoring drug history
Confusing APS-related thrombosis with inflammatory vasculitis
FAQs
1. How do you distinguish vasculitis from infection in MRCP Part 1?
Look for positive blood cultures, low complement levels, and identifiable infection sources. Infection often has microbiological evidence and responds to antibiotics.
2. Is ANCA always diagnostic?
No. ANCA can be positive in drug reactions, infections, and autoimmune diseases. It must be interpreted in clinical context.
3. What is the most common mimic in exams?
Infective endocarditis is the most frequently tested mimic due to overlapping renal, skin, and systemic features.
4. When is biopsy required?
Before starting long-term immunosuppression, especially in renal or unclear systemic disease, biopsy confirms diagnosis.
5. What is the key takeaway for MRCP Part 1?
Always exclude infection first—this is the single most important exam principle.
Ready to start?
Strengthen your diagnostic approach with targeted practice. Attempt Free MRCP MCQs and simulate real exam conditions using a Start a mock test. For a full roadmap, explore the MRCP Part 1 overview.
Sources
MRCP(UK) Syllabus: https://www.mrcpuk.org/mrcpuk-examinations/part-1
BMJ Best Practice – Vasculitis: https://bestpractice.bmj.com/topics/en-gb/3000115
EULAR Recommendations for Vasculitis: https://ard.bmj.com/content/75/9/1583
Oxford Handbook of Clinical Medicine (latest edition)



Comments